newsfilter
← Latest News
Business Wire·

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report